Amphotericin B lipid complex for neonatal invasive candidiasis

Adler-Shohet, F.;Waskin, H.;Lieberman, J. M.

Author address: 

Lieberman, JM, Miller Childrens Hosp, 2801 Atlantic Ave,POB 1428, Long Beach, CA 90801 USA

Abstract: 

This study describes the safety and efficacy of amphotericin B lipid complex (ABLC) in 11 neonates with systemic Candida infections. Nine of the 11 improved clinically, and eight of nine evaluable patients had a mycological cure with ABLC. Creatinine levels improved or did not significantly change in eight of the 11 patients.
1998

abstract No: 

NULL

Full conference title: 

36th Annual Meeting of the Infectious-Diseases-Society-of- America
    • IDSA 36th